HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Microporous Polysaccharide Hemospheres do not enhance abdominal infection in a rat model compared with gelatin matrix.

AbstractBACKGROUND:
Residual topical hemostatic material can serve as a nidus for infection or enhance infection in an already contaminated wound. A newly approved agent, Microporous Polysaccharide Hemospheres (MPH) (Arista AH), has rapid degradation properties, which may reduce the chance of surgical site infection.
MATERIALS AND METHODS:
With institutional approval, 170 Wister rats underwent standardized anesthesia and abdominal surgery. An Echerichia coli inoculum was added to the incision, and MPH, gelatin matrix, or no agent (control) was placed in the site. After 72 h, the animals were sacrificed, and colony-forming units (cfu)/g were counted in the harvested tissue.
RESULTS:
Application of gelatin matrix resulted in more cfu/g of tissue and an 87% infection rate, with fewer cfu/g of tissue and a 14% and 24% infection rate in the control and MPH groups, respectively.
CONCLUSION:
The use of MPH in this rat abdominal infection model did not enhance infection. Gelatin matrix was associated with a greater infection rate than MPH. The rapid degradation of MPH may account for these results, making it a good hemostat in the presence of infective sources.
AuthorsMark H Ereth, Yue Dong, Lisa M Schrader, Nicolle A Henderson, Shvetank Agarwal, William C Oliver, Gregory A Nuttall
JournalSurgical infections (Surg Infect (Larchmt)) Vol. 10 Issue 3 Pg. 273-6 (Jun 2009) ISSN: 1557-8674 [Electronic] United States
PMID19485784 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Polysaccharides
  • Gelatin
Topics
  • Animals
  • Colony Count, Microbial
  • Equipment and Supplies
  • Escherichia coli (isolation & purification)
  • Escherichia coli Infections
  • Gelatin
  • Hemostasis, Surgical (adverse effects)
  • Polysaccharides
  • Rats
  • Rats, Wistar
  • Surgical Wound Infection (etiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: